Advanced therapies for heart failure: heart transplantation vs. LVAD. How to choose? Expert opinion
An expert commentary by Dra. Sonia Mirabet about choices for advanced heart failure therapies.
An expert commentary by Dra. Sonia Mirabet about choices for advanced heart failure therapies.
A systematic review analyzing nearly 1000 pediatric Berlin Heart® implants to describe the characteristics of patients who achieved successful explantation.
This study, conducted at a tertiary pediatric cardiology center, evaluates the long-term use of ventricular assist devices (VADs).
This state-of-the-art document discusses current guidelines on indications and utility of invasive hemodynamic assessment in patients with advanced heart failure (HF) undergoing treatment with continuous-flow left ventricular assist devices (LVADs).
Review article from Thoracic and Cardiovascular Surgeon that revisits the most relevant articles published in 2022 in the field of cardiac surgery.
This JACC scientific statement summarizes the progress and challenges of durable ventricular assist devices (VADs) for patients with advanced heart failure, contextualizing current therapy and outcomes, and discussing future technology and priorities.
Outcomes of VA-ECMO weaning for cardiogenic shock of various etiologies at Columbia University Irving Medical Center, assessed at both 30-day/hospital discharge and 1-year follow-up among survivors.
This multicenter, observational, and retrospective study analyzes the utility and complications associated with implantable cardioverter-defibrillators (ICDs) in patients with long-term left ventricular assist devices (LVADs).
A retrospective study analyzing the evolution of all SynCardia® total artificial heart (TAH) implants as a bridge to transplantation in the United States from 2005 to 2018.
The EARLY-UNLOAD study is a single-center, prospective clinical trial comparing early initiation of routine LV unloading in cardiogenic shock (CS) patients supported by veno-arterial extracorporeal membrane oxygenation (VA-ECMO) against conventional management.